PWC
AMGN icon

Pathfinder Wealth Consulting’s Amgen AMGN Stock Holding History

Pathfinder Wealth Consulting’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,125
Closed -$396K – 7
2026
Q1 		$396K Sell
1,125
-155
-12% -$55.3K 0.26% 92
2025
Q4 		$419K Buy
+1,280
New +$406K 0.26% 89

Other funds holding AMGN

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
SP
Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
AWA
Aaron Wealth Advisors Chicago, Illinois $1.97B AUM 36.91% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Pathfinder Wealth Consulting's AMGN Position: Q2 2026 in Review

Pathfinder Wealth Consulting sold out of Amgen (AMGN) in Q2 2026, closing a stake of 1,125 shares — an estimated $396K sold.

Pathfinder Wealth Consulting first reported a position in AMGN in Q4 2025 and held it in 2 quarters. The position peaked at $419K in Q4 2025. 547 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Pathfinder Wealth Consulting reported no remaining Amgen position as of Q2 2026 after selling out during the quarter.
  • Pathfinder Wealth Consulting sold 1,125 Amgen shares in Q2 2026, an estimated $396K.
  • Pathfinder Wealth Consulting first reported a position in Amgen in Q4 2025 and held it in 2 quarters.
  • Pathfinder Wealth Consulting's Amgen position peaked at $419K in Q4 2025.
  • 547 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Pathfinder Wealth Consulting's 13F filing for Q2 2026.